Vestcor Inc’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Vestcor Inc’s Portfolio PRVL Stock Details PRVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100,000	Closed	-$2.31M	–	1300
2020 Q4	$2.31M	Buy	+100,000	New	+$1.27M	0.1%	257

Vestcor Inc's PRVL Position: Q1 2021 in Review

Vestcor Inc sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 100,000 shares — an estimated $2.31M sold.

Vestcor Inc first reported a position in PRVL in Q4 2020 and held it in 1 quarter. The position peaked at $2.31M in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

Vestcor Inc reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Vestcor Inc sold 100,000 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $2.31M.
Vestcor Inc first reported a position in Prevail Therapeutics Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Vestcor Inc's Prevail Therapeutics Inc. Common Stock position peaked at $2.31M in Q4 2020.
0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Vestcor Inc's 13F filing for Q1 2021, filed 17 May 2021.